OWC Pharmaceutical Research Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 6/08/2016
Contact Info
  • 22 Shacham St.
  • PO Box 8324
  • Petach-Tikva 4918002
  • Israel

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001431934
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2008
Employees 6 a/o Feb 25, 2016
Company Officers/Contacts
Mordechai Bignitz CEO, President
Ziv Turner COO
Shmuel De-Saban CFO
Dr. Asaf Toker Chief Scientific Officer
Yehuda Baruch Chief Scientific Officer, Director, R&D
Richard Rubin Counsel
Company Directors
Mordechai Bignitz Chairman
Company Notes
  • Formerly=Dynamic Applications Corp. until 1-2015
Service Providers
Accounting/Auditing Firm
4100 North Sam Houston Pkwy W
Suite 200-B
Houston, TX, 77086
United States

Legal Counsel
Thomas J. Craft, Jr. Esq.
5420 North Ocean Drive
Ste. 2102
Singer Island, FL, 33404
United States

Office of Richard Rubin
40 Wall Street 28th Floor
New York, NY, 10005
United States

Investor Relations Firm
Not Available
OWCP Security Details
Share Structure
Market Value1 $14,581,497 a/o Oct 21, 2016
Authorized Shares 500,000,000 a/o Sep 23, 2016
Outstanding Shares 81,460,875 a/o Oct 18, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 33,515,750 a/o Apr 20, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 128 a/o Aug 16, 2016
Short Selling Data
Short Interest 5,247 (20,888%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security